Related Experiment Video
Updated: Dec 28, 2025

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
Published on: February 23, 2020
Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm
Yuchen He1, Jia Xing2, Shiyue Wang1
1Department of Vascular Surgery, The First Hospital of China Medical University, Key Laboratory of Pathogenesis, Prevention, and Therapeutics of Aortic Aneurysm, Shenyang 110001, China.
Background:
The role of N6-methyladenosine (m6A) modification in abdominal aortic aneurysm (AAA) has not been extensively studied. This study therefore aimed to investigate m6A RNA methylation and the expressions of the corresponding modulators in AAA.
Methods:
A comparative study between AAA tissue samples (n=32) and healthy aortas (n=12) was performed using m6A methylation quantification for messenger RNA (mRNA) m6A status, quantitative polymerase chain reaction (qPCR), and western blot for the expressions of m6A modulators and immunohistochemistry (IHC) to detect locations of the modulators in AAA tissues.
Results:
The m6A level significantly increased in AAA as compared to healthy aorta tissues. Among AAA patients, the high m6A level represented an even greater risk of AAA rupture as compared to non-ruptured AAA [odds ratio (OR), 1.370; 95% confidence interval (CI), 1.007-1.870]. The major N6-adenosine modulators, including YTHDF1, YTHDF3, FTO, and METTL14, are the main factors involved in aberrant m6A modification and the expression of both was significantly correlated to the proportion of m6A in total mRNA. Clinically, YTHDF3 represented an even greater risk of rupture (OR, 1.036; 95% CI, 1.001-1.072). Regarding the cellular location, METTL14 seemed to be associated with inflammatory infiltrates and neovascularization. Furthermore, a strong correlation was seen between FTO and aneurysmal smooth muscle cells (SMCs), YTHDF3, and macrophage infiltrate.
Conclusions:
We were first to observe m6A modification in human AAA tissues. The results also reveal the important roles of m6A modulators, including YTHDF3, FTO, and METTL14, in the pathogenesis of human AAA and provide a new view on m6A modification in AAA. Our findings suggest a potential mechanism of epigenetic alterations in clinical AAA.
Insights
N6-methyladenosine (m6A) levels are elevated in abdominal aortic aneurysm (AAA) and linked to rupture risk. Key m6A modulators like YTHDF3 and FTO play significant roles in AAA pathogenesis.
Area of Science:
- Molecular Biology
- Epigenetics
- Cardiovascular Research
Background:
- Abdominal aortic aneurysm (AAA) pathogenesis is complex and not fully understood.
- The role of N6-methyladenosine (m6A) RNA modification in AAA remains largely unexplored.
- This study investigates m6A RNA methylation and its modulators in human AAA tissues.
Purpose of the Study:
- To investigate m6A RNA methylation levels in AAA tissues compared to healthy aortas.
- To identify and analyze the expression of key m6A RNA modulators in AAA.
- To explore the correlation between m6A modification, its modulators, and AAA characteristics, including rupture risk.
Main Methods:
- Comparative analysis of AAA tissues (n=32) and healthy aortas (n=12).
- Quantification of mRNA m6A status.
- Quantitative PCR (qPCR) and Western blot for m6A modulator expression.
- Immunohistochemistry (IHC) for cellular localization of modulators.
Main Results:
- Significantly increased m6A levels were observed in AAA tissues compared to healthy aortas.
- Elevated m6A levels correlated with an increased risk of AAA rupture.
- Key m6A modulators (YTHDF1, YTHDF3, FTO, METTL14) showed aberrant expression correlated with m6A levels.
- YTHDF3 expression was associated with increased rupture risk; METTL14 with inflammatory infiltrates; FTO with smooth muscle cells; YTHDF3 with macrophage infiltrate.
Conclusions:
- This is the first study to report m6A modification in human AAA tissues.
- m6A modulators, including YTHDF3, FTO, and METTL14, are implicated in AAA pathogenesis.
- Findings suggest a potential role for epigenetic alterations in clinical AAA development and progression.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm III: Interprofessional Care

